World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
111
Citations
68239
World Ranking
5239
National Ranking
517

Peter S. Sever publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter S. Sever sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 542 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter S. Sever D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter S. Sever sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 111 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter S. Sever is affiliated with Imperial College London in the United Kingdom. Their research predominantly centers on medicine, with a substantial focus on cardiology and cardiovascular medicine. Other significant areas of study include surgery, economics and econometrics, endocrinology, diabetes and metabolism, and physiology.

The scientist's work covers several main topics, which include:

  • Lipoproteins and Cardiovascular Health
  • Blood Pressure and Hypertension Studies
  • Health Systems, Economic Evaluations, Quality of Life
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Acute Myocardial Infarction Research
  • Pharmaceutical Economics and Policy
  • Alzheimer's disease research and treatments

Publications by Peter S. Sever have appeared frequently in several academic venues, such as:

  • European Heart Journal
  • Journal of Hypertension
  • Circulation
  • The Lancet
  • JAMA Cardiology

Recent papers include:

  • Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials (2020, The Lancet)
  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials (2022, The Lancet)
  • Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment (2021, Journal of the American College of Cardiology)
  • Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction (2020, JAMA Cardiology)
  • Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy (2020, JAMA Cardiology)

Peter S. Sever frequently collaborates with several co-authors, including:

  • Ajay Gupta
  • Anthony Keech
  • Robert P. Giugliano
  • Marc S. Sabatine
  • Somayeh Rostamian

Best Publications

  • Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

    Marc S. Sabatine;Robert P. Giugliano;Anthony C. Keech;Narimon Honarpour

  • Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

    Peter S Sever;Björn Dahlöf;Neil R Poulter;Hans Wedel

  • Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

    Björn Dahlöf;Peter S Sever;Neil R Poulter;Hans Wedel

  • Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.

    Peter M Rothwell;Sally C Howard;Eamon Dolan;Eoin O'Brien

  • Defining the role of common variation in the genomic and biological architecture of adult human height

    Andrew R. Wood;Tonu Esko;Jian Yang;Sailaja Vedantam

  • Interpretation of the evidence for the efficacy and safety of statin therapy.

    Rory Collins;Christina Reith;Jonathan Emberson;Jane Armitage

  • Genetic studies of body mass index yield new insights for obesity biology

    Adam E. Locke;Bratati Kahali;Sonja I. Berndt;Anne E. Justice

  • Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits.

    Evangelos Evangelou;Evangelos Evangelou;Helen R. Warren;Helen R. Warren;David Mosen-Ansorena;Borbala Mifsud

  • Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV

    Williams B;Poulter Nr;Brown Mj;Davis M

  • Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries

    Mary F. Feitosa;Aldi T. Kraja;Daniel I. Chasman;Yun J. Sung

  • Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

    Bryan Williams;Thomas M MacDonald;Steve Morant;David J Webb

  • British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary

    Bryan Williams;Neil R Poulter;Morris J Brown;Mark Davis

  • Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke

    Peter M Rothwell;Sally C Howard;Eamon Dolan;Eoin O'Brien

  • Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled Trial

    Peter S Sever;Björn Dahlöf;Neil R Poulter;Hans Wedel

  • HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

    Daniel I Swerdlow;David Preiss;Karoline B Kuchenbaecker;Michael Holmes

  • Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension

    Neil Chapman;Joanna Dobson;Sarah Wilson;Björn Dahlöf

  • Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.

    Michelle L. O’Donoghue;Sergio Fazio;Robert P. Giugliano;Erik S.G. Stroes

  • Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)

    Marc P. Bonaca;Patrice Nault;Robert P. Giugliano;Anthony C. Keech

  • Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials

    Jessica L Mega;Nathan O Stitziel;J Gustav Smith;J Gustav Smith;Daniel I Chasman

  • Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits

    Evangelos Evangelou;Helen R. Warren;David Mosen-Ansorena;Borbala Mifsu

Frequent Co-Authors

Neil R. Poulter
Neil R. Poulter Imperial College London
Mark J. Caulfield
Mark J. Caulfield Queen Mary University of London
Patricia B. Munroe
Patricia B. Munroe Queen Mary University of London
Nilesh J. Samani
Nilesh J. Samani University of Leicester
Alun D. Hughes
Alun D. Hughes University College London
Jaspal S. Kooner
Jaspal S. Kooner Imperial College London
Weihua Zhang
Weihua Zhang Imperial College London
John C. Chambers
John C. Chambers Guy's and St Thomas' NHS Foundation Trust
Tonu Esko
Tonu Esko University of Tartu
Bruce M. Psaty
Bruce M. Psaty University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those inspired to make a difference in healthcare, there are a variety of flexible, online education options to support your journey. One popular choice is exploring lpn to rn programs without teas test, allowing Licensed Practical Nurses to advance their careers without extra exam barriers.

If you’re interested in the administrative side of medicine, a healthcare administration associate degree online can prepare you for roles in managing healthcare facilities, policy, or medical records.

Registered Nurses aiming to become Nurse Practitioners can consider rn to np bridge programs to efficiently earn advanced credentials online while continuing to work.

Nutrition and wellness are also in demand in today’s healthcare landscape. Those passionate about diet and preventive health can pursue an online dietitian degree, opening doors to careers in clinical practice, public health, or education.

Whichever path you choose, these online degrees provide the flexibility and access needed to start or advance your healthcare career on your own schedule.

Best Scientists Citing Peter S. Sever

Trending Scientists

Recently Published Articles